Press "Enter" to skip to content

C2 Pharma doubles down on supplies of digoxin API

Luxembourg-based C2 Pharma, which already has a manufacturing agreement with Laurus Labs in India, has now bought a new supply of digoxin API. (Lauras Labs) C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes difficult-to-get drug. The Luxembourg-based company has acquired the digoxin API product portfolio of Polish company Nobilus. The company said that through the agreement, C2 Pharma is the product owner and Nobilus is a manufacturing partner and releasing entity for the API. Terms of the deal were […]

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *